Key facts
- TINFE HTS’s last known valuation is $600K (Jun 2025).
- It has raised $110K; the latest was Accelerator/Incubator ($30K) in Jun 2025.
- Notable investors include Vesna Deep Tech Fund, HAMAG-BICRO, Nucleus (Other Commercial Services), Zicer.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for TINFE HTS
- ·The full record, as it builds
Funding rounds
No funding rounds for TINFE HTS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TINFE HTS
Developer of fluorescence analysis software designed to improve measurement accuracy and efficiency. The company's software offers tools featuring inner filter effect correction, multi-instrument compatibility, automated signal processing, and data output, enabling research professionals and diagnostic labs to reduce sample preparation, streamline workflows, and obtain insights from samples.
- Sector
- Healthcare
- HQ
- Zagreb, Croatia
- Founded
- 2024
- Employees
- 2
- Website
- tinfe.tech/
- Ownership
- Privately Held (backing)
TINFE HTS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TINFE HTS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TINFE HTS in its N-PORT filings yet. We sweep new filings monthly.